Impact of statins on glucose metabolism - A matter of debate

American Journal of Cardiology

Volumn 107, Issue 12, 2011, Pages 1866-

  Anagnostis, Panagiotis ^a   Athyros, Vasilios G ^a   Karagiannis, Asterios ^a   Mikhailidis, Dimitri P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ATORVASTATIN; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; LEPTIN; ROSUVASTATIN; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; DRUG EFFECT; DYSLIPIDEMIA; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

FLUOROBENZENES; GLUCOSE; HEPTANOIC ACIDS; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN RESISTANCE; PYRIMIDINES; PYRROLES; SULFONAMIDES;

EID: 79957968590     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.018     Document Type: Letter

References (5)

1. N. Thongtang, M. Ai, S. Otokozawa, T.V. Himbergen, B.F. Asztalos, K. Nakajima, E. Stein, P.H. Jones, and E.J. Schaefer Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation Am J Cardiol 107 2011 387 392
2. P. Anagnostis, D. Selalmatzidou, S.A. Polyzos, A. Panagiotou, A. Slavakis, A. Aikaterini Panagiotidou, V.G. Athyros, A. Karagiannis, D.P. Mikhailidis, and M. Kita Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomized open-label study Int J Clin Pract 2011 [Epub ahead of print]
3. A.Y. Her, J.Y. Kim, S.M. Kang, D. Choi, Y. Jang, N. Chung, I. Manabe, and S.H. Lee Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism J Cardiovasc Pharmacol Ther 15 2010 167 174
4. N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, A.J. de Craen, S.R. Seshasai, J.J. McMurray, D.J. Freeman, J.W. Jukema, P.W. Macfarlane, C.J. Packard, D.J. Stott, R.G. Westendorp, J. Shepherd, B.R. Davis, S.L. Pressel, R. Marchioli, R.M. Marfisi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J. Kjekshus, T.R. Pedersen, T.J. Cook, A.M. Gotto, M.B. Clearfield, J.R. Downs, H. Nakamura, Y. Ohashi, K. Mizuno, K.K. Ray, and I. Ford Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
5. C.I. Coleman, K. Reinhart, J. Kluger, and C.M. White The effect of statins on the development of new onset type 2 diabetes: a meta-analysis of randomized controlled trials Curr Med Res Opin 24 2008 1359 1362 (Pubitemid 351741567)